BioSpace News Archive

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the “Company” or “EXM”), an emerging bio-science company specializing in the production of unique cannabinoid formulations, is pleased to announce the advancement of its R&D operations at its Lisbon, Portugal, facility.

BioAge Plans Phase 2 Clinical trial in Hospitalized COVID-19 Patients Clinical development plan supported by potent inhibition of PGD2 DP1 Receptor by BGE-175 , activating immune-modulating mechanisms that result in 100% survival in aged preclinical models of coronavirus BioAge’s proprietary human aging data links activation of PGD2 DP1 signaling to increased risk of mortality and susceptibility to infections RICHMOND, Calif., Aug. 25, 2020 (GLOBE NEWSWIRE) -- BioAge Labs, Inc., a biot

AbbVie (NYSE: ABBV) and Harvard University today announced a $30 million collaborative research alliance, launching a multi-pronged effort at Harvard Medical School (HMS) to study and develop novel therapies against emergent viral infections, with a focus on those caused by coronaviruses and by vi

Study builds on extensive research showing that granulocyte-macrophage colony stimulating factor (GM-CSF) is needed for effective immune function in the lungs iLeukPulm Phase 2 Clinical TrIal Supported by $35 Million Contract from U.S. Department of Defense [25-August-2020] LEXINGTON, Mass. , Aug. 25, 2020 /PRNewswire/ -- Partner Therapeutics, Inc. (PTx), a

Most adults with systemic lupus erythematosus are not at increased risk of hospitalization from COVID-19 due to medications used to dampen their altered immune system, the cause of their disease.

In the most comprehensive study of its kind on the effects of the Music & Memory program, researchers from the Betty Irene Moore School of Nursing at UC Davis found that personalized music is associated with a reduction in the amount of antipsychotic medication taken by nursing home residents and fewer distressed behaviors

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that Brian M. Culley, Chief Executive Officer, will be presenting at the LD Micro 500 Virtual Investor Conference on September 1, 2020 at 9:40 am Eastern Time / 6:40 am Pacific Time. Brian M. Culley and Brandi L. Roberts, Chief Financial

NowRx , a tech-enabled on-demand pharmacy providing same-day and same-hour prescription delivery, today announced that it will be presenting at the LD 500 Investor Conference on September 3, 2020 at 8:40 a.m. ET / 5:40 a.m. PT. Cary Breese, CEO and Co-Founder of NowRx, will be presenting to a live virtual audience. Retail pharmacy is a $400 billion industry that relies on expensive real estate to drive foot traffic and depends on outdate

Proceeds to support Lung Association mission to save lives and prevent lung disease through education, advocacy and research

ExsoMed Corporation, a privately held U.S.-based medical device company providing orthopaedic surgeons with innovative solutions in hand surgery, today announced that 5,000 metacarpal fractures have been successfully treated with the INnate Intramedullary Threaded Nail.